Abstract

Development of Tat-fused drug binding protein to improve anti-cancer effect of mammalian target of rapamycin inhibitors

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call